Covered recipient · General Payments record
SAMYUKTHA KEMPARAJURS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,861.54
- Reported across 183 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $342.32 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.08 | 14 |
| Novo Nordisk AS | $45.86 | 2 |
| Acerta Pharma LLC | $44.59 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.50 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.83 | 1 |
| GlaxoSmithKline, LLC. | $15.17 | 1 |
| Amgen Inc. | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.04 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051200 | CMS |
| ABBVIE INC. | $5.95 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051202 | CMS |
| ABBVIE INC. | $20.28 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051204 | CMS |
| ABBVIE INC. | $16.57 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051206 | CMS |
| ABBVIE INC. | $24.01 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051208 | CMS |
| ABBVIE INC. | $20.29 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051210 | CMS |
| ABBVIE INC. | $1.99 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051212 | CMS |
| ABBVIE INC. | $7.50 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051214 | CMS |
| ABBVIE INC. | $7.71 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051216 | CMS |
| ABBVIE INC. | $13.80 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051218 | CMS |
| ABBVIE INC. | $10.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051220 | CMS |
| ABBVIE INC. | $12.50 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051222 | CMS |
| ABBVIE INC. | $5.50 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051224 | CMS |
| ABBVIE INC. | $16.94 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104051226 | CMS |
| Amgen Inc. | $14.29 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117596250 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.99 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104605682 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.18 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105686677 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.42 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104718189 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $26.50 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086268431 | CMS |
| GlaxoSmithKline, LLC. | $15.17 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116547347 | CMS |
| Novartis Pharmaceuticals Corporation | $22.83 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087145570 | CMS |
| Novo Nordisk Inc | $23.16 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097222136 | CMS |
| Novo Nordisk Inc | $22.70 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097636809 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.